Cochlear ( ($AU:COH) ) has provided an announcement. Cochlear Limited announced a change in the director’s interest, specifically for Director ...

The company says its epilepsy treatment will be far more effective and less invasive than other options as it prepares for ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited, a leader in implantable hearing solutions, reported a successful year with record sales revenue and profit growth. The company ...

Cochlear Limited announced the issuance of unquoted equity securities under its employee incentive scheme, which includes options and performance rights. This move is part of the company’s strategy to ...

In a report released on February 14, David Low from J.P. Morgan upgraded Cochlear Limited (CHEOF – Research Report) to a Buy, with a price target of A$311.00. The company’s shares closed last Friday ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Morgan Stanley analyst Sean Laaman downgraded Cochlear Limited (CHEOF – Research Report) to a Sell today and set a price target of A$240.00. The company’s shares closed last Wednesday at $176.30.

Jody McDonald is a freelance writer based in Brisbane who specialises in writing about business, technology and the future of work. She’s helped a range of SaaS platforms and tech companies share ...

It is hard to get excited after looking at Cochlear's (ASX:COH) recent performance, when its stock has declined 7.6% over the past three months. However, a closer look at its sound financials might ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear ( (AU:COH)) has shared an update ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.